- Report
- June 2025
- 198 Pages
Global
From €4578EUR$4,950USD£3,826GBP
- Report
- June 2025
- 90 Pages
United States
From €1849EUR$1,999USD£1,545GBP
- Report
- May 2025
- 600 Pages
Global
From €1295EUR$1,400USD£1,082GBP
- Report
- May 2025
- 600 Pages
Global
From €1295EUR$1,400USD£1,082GBP
- Report
- April 2025
- 225 Pages
Global
From €4162EUR$4,500USD£3,479GBP
- Report
- April 2025
- 44 Pages
United States
- Report
- March 2025
- 145 Pages
Global
From €4486EUR$4,850USD£3,749GBP
- Report
- March 2025
- 260 Pages
Middle East
From €2682EUR$2,900USD£2,242GBP
- Report
- March 2025
- 260 Pages
Africa
From €2682EUR$2,900USD£2,242GBP
- Report
- March 2025
- 210 Pages
Latin America
From €2682EUR$2,900USD£2,242GBP
- Report
- March 2025
- 840 Pages
Asia Pacific
From €2682EUR$2,900USD£2,242GBP
- Report
- March 2025
- 980 Pages
Europe
From €2682EUR$2,900USD£2,242GBP
- Report
- March 2025
- 1400 Pages
Global
From €4532EUR$4,900USD£3,788GBP
- Report
- March 2025
- 50 Pages
Kenya
From €555EUR$600USD£464GBP
- Report
- March 2025
- 50 Pages
Nigeria
From €555EUR$600USD£464GBP
- Report
- March 2025
- 50 Pages
Egypt
From €555EUR$600USD£464GBP
From €555EUR$600USD£464GBP
- Report
- March 2025
- 50 Pages
Greece
From €555EUR$600USD£464GBP
- Report
- March 2025
- 50 Pages
Finland
From €555EUR$600USD£464GBP
- Report
- March 2025
- 50 Pages
Denmark
From €555EUR$600USD£464GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more